Serum NFL discriminates Parkinson disease from atypical parkinsonisms

Erstveröffentlichung
2019
Metadata only
Search for full text
Wissenschaftlicher Artikel


Authors
Marques, Taina M.
van Rumund, Anouke
Oeckl, Patrick
Kuiperij, H. Bea
Esselink, Rianne A. J.
et al.
Institutions
UKU. Klinik für Neurologie
Published in
Neurology ; 92 (2019), 13. - S. E1479-E1486. - ISSN 0028-3878. - eISSN 1526-632X
Link to publication
https://dx.doi.org/10.1212/WNL.0000000000007179
Funding information
Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [249032/2013-9]
van Alkemade-Keuls Fonds
JPND network (PreFrontAls)
German Federal Ministry of Education and Research [FTLDc O1GI1007]
EU [FAIRPARK II 633190]
etc.
EU Project
FAIR-PARK-II / Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone / EC / H2020 / 633190
Dewey Decimal Group
DDC 610 / Medicine & health
Metadata
Show full item record